Department of Pharmacy, University of Peshawar, Peshawar 25120, KP, Pakistan.
Mumtaz Maternity Hospital, Hashtnagri, Peshawar 25220, KP, Pakistan.
Molecules. 2023 Mar 13;28(6):2606. doi: 10.3390/molecules28062606.
The convenient and highly compliant route for the delivery of active pharmaceutical ingredients is the tablet. A versatile platform of tablets is available for the delivery of therapeutic agents to the gastrointestinal tract. This study aimed to prepare gastro retentive drug delivery floating tablets of silymarin to improve its oral bioavailability and solubility. Hydroxypropyl methylcellulose (HPMCK4M and HPMCK15), Carbopol 934p and sodium bicarbonate were used as a matrix, floating enhancer and gas generating agent, respectively. The prepared tablets were evaluated for physicochemical parameters such as hardness, weight variation, friability, floating properties (floating lag time, total floating time), drug content, stability study, in vitro drug release, in vivo floating behavior and in vivo pharmacokinetics. The drug-polymer interaction was studied by Differential Scanning Calorimetry (DSC) thermal analysis and Fourier transform infrared (FTIR). The floating lag time of the formulation was within the prescribed limit (<2 min). The formulation showed good matrix integrity and retarded the release of drug for >12 h. The dissolution can be described by zero-order kinetics (r = 0.979), with anomalous diffusion as the release mechanism ( = 0.65). An in vivo pharmacokinetic study showed that Cmax and AUC were increased by up to two times in comparison with the conventional dosage form. An in vivo imaging study showed that the tablet was present in the stomach for 12 h. It can be concluded from this study that the combined matrix system containing hydrophobic and hydrophilic polymers min imized the burst release of the drug from the tablet and achieved a drug release by zero-order kinetics, which is practically difficult with only a hydrophilic matrix. An in vivo pharmacokinetic study elaborated that the bioavailability and solubility of silymarin were improved with an increased mean residence time.
方便且高度顺应的活性药物成分传递途径是片剂。有多种片剂平台可用于将治疗剂递送至胃肠道。本研究旨在制备水飞蓟素胃滞留型药物传递漂浮片剂,以提高其口服生物利用度和溶解度。羟丙基甲基纤维素(HPMCK4M 和 HPMCK15)、Carbopol 934p 和碳酸氢钠分别用作基质、漂浮增强剂和气体生成剂。对制备的片剂进行了物理化学参数的评估,如硬度、重量变化、脆碎度、漂浮性能(漂浮滞后时间、总漂浮时间)、药物含量、稳定性研究、体外药物释放、体内漂浮行为和体内药代动力学。通过差示扫描量热法(DSC)热分析和傅里叶变换红外(FTIR)研究了药物-聚合物相互作用。该制剂的漂浮滞后时间在规定范围内(<2 分钟)。该制剂表现出良好的基质完整性,并将药物释放延迟超过 12 小时。溶解可以用零级动力学(r = 0.979)来描述,释放机制为异常扩散( = 0.65)。体内药代动力学研究表明,与常规剂型相比,Cmax 和 AUC 增加了两倍。体内成像研究表明,片剂在胃中存在 12 小时。可以从这项研究中得出结论,包含疏水和亲水聚合物的组合基质系统最大限度地减少了药物从片剂中的突释,并通过零级动力学实现了药物释放,仅使用亲水基质在实践中很难实现。体内药代动力学研究详细阐述了水飞蓟素的生物利用度和溶解度得到了提高,平均滞留时间延长。